The U.S. liquid embolic agent market size was valued at USD 66.28 million in 2024, with projections indicating a CAGR of 9.0% between 2025 and 2034, underscoring the accelerating adoption of minimally invasive procedures in interventional neurology and oncology. While the U.S. remains the most mature and revenue-dominant market, the growth trajectory of liquid embolic agents is shaped not only...
Dutch 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek